Accelerating Precision Medicine through Innovation

Break-through core biopsy device with patented dual needle technology

The realization of personalized medicine is upon us as more and more cancers can be classified on their genetic signatures. These sub-types can be targeted with tailored treatments that more effectively can combat the cancer and possibly reduce the overall side effects. The most reliable material to test a potential treatment compound is an actual sample of fresh tumor.

Our innovative dual needle core biopsy instrument, Precision BX-1, ensures the collection of two samples directly adjacent to each other, guaranteeing homogeneity of the samples. One sample is dedicated to microscopic diagnostic evaluation, while the second is preserved for advanced genetic and molecular studies. This approach maximizes the use of valuable tissue, ensuring that only confirmed diagnostic samples proceed to expensive molecular testing—eliminating unnecessary analysis and optimizing precision medicine for better patient outcomes.

Explore Precision BX-1

Validation Study

Let's Collaborate!

Validation | Case 1 Metastatic Neuroendocrine Carcinoma to the the Ovary

Validation | Case 3 Renal Cell Carcinoma

Validation | Case 4 Uterus Endometrial Carcinoma

News & Stories

Join Us at ISBER 2025 - Booth 17!

Come see us at the 25th ISBER Annual Meeting, the leading global forum for biobanking leadership, on May 12-16, 2025 at our exhibit table or our presentation! Don’t miss Rocky Ackroyd’s presentation on May 13, where he’ll share the exciting validation of our Dual Needle Core Biopsy technology.
Poster Presentation at Tucson Symposium

Don’t miss Rocky Ackroyd at the 21st Annual Tucson Symposium on April 1, 2025, doing a poster presentation! This prestigious event brings together top cancer experts to drive advancements in pathology and oncology. Don’t miss Rocky’s insights on the validation of our Dual Needle Core Biopsy technology—paving the way for more precise cancer diagnostics and research.
Secured Patent for Our Dual Needle Core Biopsy!

We are thrilled to announce that RockPoint Biopsy has been granted a patent for our innovative Dual Needle Core Biopsy technology! This milestone reinforces our commitment to advancing precision medicine by increasing access to high-quality tissue samples for both diagnosis and research.